Among the FPC cohorts, ATM (3.09%) and BRCA2 (2.61%), two genes associated with breast and ovarian cancer, had the highest prevalence of PVs followed by CDKN2A (2.24%), the major high-risk susceptibility gene involved in familial melanoma (Table 2). This evidence concerns the gene CDKN2A and familial melanoma.